Dive Brief:
- U.S. digital health startups nabbed a record $29.1 billion in funding in 2021, nearly double the investment volume in the year prior, according to a new report from Rock Health.
- That was across 729 deals, with an average deal size of almost $40 million. Digital health companies catalyzing research and development in biopharma and medtech brought in the most funding, helped by pandemic-era adoption of real-world evidence and decentralized trials, the seed fund said.
- Most of the funding growth was driven by megarounds of $100 million or above. Last year had 88 such deals, which brought in $16.6 billion — more than half the year’s total.
Read rest of story here: https://www.pharmexec.com/view/biopharma-companies-must-go-all-in-on-patient-centricity